Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CareDx Inc (CDNA)
:CDNA
Holding CDNA?
Track your performance easily
CDNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.42 - $34.84
Previous CloseN/A
Volume177.07K
Average Volume (3M)795.23K
Market Cap
$1.18B
Enterprise Value$1.44B
Total Cash (Recent Filing)$17.26M
Total Debt (Recent Filing)$1.10M
Price to Earnings (P/E)―
Beta1.71
Next Earnings
Feb 26, 2025EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.70
Shares Outstanding53,633,870
10 Day Avg. Volume984,374
30 Day Avg. Volume795,227
Standard Deviation0.23
R-Squared0.17
Alpha0.00347
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.78
Price to Cash Flow (P/CF)23.60
P/FCF Ratio27.30
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue4.61
Enterprise Value/Gross Profit8.08
Enterprise Value/Ebitda-47.93
Forecast
1Y Price Target
$31.25Price Target Upside41.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
CareDx News
PremiumCompany Announcements
CareDx Announces Strong Revenue Growth and Outlook
PremiumCompany Announcements
CareDx Updates Director Compensation and Vesting Policies
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTotal revenue grew 23% YoY in 3Q24, beating analyst projections.
Regulatory And ComplianceDOJ concluded its investigation into the company with no finding of wrongdoing and declined to take any further action.
Strategic Growth PlansCareDx is targeting 15% CAGR growth to reach $500M in revenue in 2027.
Bears Say
Financial PerformanceNet loss was between $32-34M for 4Q24 and between $58-60M for FY2024.
Management GuidanceSurprisingly, management did not update its '24 guidance, which is viewed as negative.
Market ExpectationsShares fell as investors wanted more upside to 3Q revenues and volumes.
---
Ownership Overview
8.01% Insiders
25.14% Mutual Funds
0.08% Other Institutional Investors
44.37% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CDNA FAQ
What was CareDx Inc’s price range in the past 12 months?
CareDx Inc lowest stock price was $7.42 and its highest was $34.84 in the past 12 months.
What is CareDx Inc’s market cap?
CareDx Inc’s market cap is $1.18B.
When is CareDx Inc’s upcoming earnings report date?
CareDx Inc’s upcoming earnings report date is Feb 26, 2025 which is in 38 days.
How were CareDx Inc’s earnings last quarter?
CareDx Inc released its earnings results on Nov 04, 2024. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.246 by $0.106.
Is CareDx Inc overvalued?
According to Wall Street analysts CareDx Inc’s price is currently Undervalued.
Does CareDx Inc pay dividends?
CareDx Inc does not currently pay dividends.
What is CareDx Inc’s EPS estimate?
CareDx Inc’s EPS estimate is -0.34.
How many shares outstanding does CareDx Inc have?
CareDx Inc has 53,633,870 shares outstanding.
What happened to CareDx Inc’s price movement after its last earnings report?
CareDx Inc reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.246. Following the earnings report the stock price went down -0.131%.
Which hedge fund is a major shareholder of CareDx Inc?
Among the largest hedge funds holding CareDx Inc’s share is ARK Investment Management LLC. It holds CareDx Inc’s shares valued at 93M.
---
CareDx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$31.25 (41.66% Upside)
$31.25 (41.66% Upside)
Blogger Sentiment
Neutral
CDNA Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.5%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
115.69%
12-Months-Change
Fundamentals
Return on Equity
-43.02%
Trailing 12-Months
Asset Growth
-4.83%
Trailing 12-Months
Company Description
CareDx Inc
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
---
CDNA Company Deck
---
CDNA Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with strong growth metrics and achievements, such as significant revenue growth, positive EBITDA, and resolution of legal matters. However, there were some concerns about the flat revenue growth expected in Q4 and the impact of external factors like Hurricane Milton. Overall, the positive aspects outweighed the negative, showing a strong growth trajectory for CareDx.Read More>---
CDNA Stock 12 Month Forecast
Average Price Target
$31.25
▲(41.66% Upside)
Technical Analysis
Castle Biosciences
―
Guardant Health
―
Roche Holding
―
QuidelOrtho
―
Exact Sciences
―
Natera
―
Best Analysts Covering CDNA
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
-6.60%
reiterated a buy rating 3 months ago
Copying Matthew Sykes's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -6.60% per trade.
---